Contact
Krystle Ficco
Feinstein Kean Healthcare
617.761.6702
- 03.18.13
- Genocea Publishes Preclinical Data for Investigational Vaccine Candidate for HSV-2
- 03.12.13
- Industry Veteran Katrine Bosley Joins Genocea Biosciences’ Board of Directors
- 10.10.12
- Genocea Closes $30 Million in Series C Financing
- 08.15.12
- Genocea Initiates a Phase 1/2a Study with its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)
- 08.05.12
- Genocea Unveils Protective Therapeutic Vaccine for Herpes Simplex Virus Type 2 (HSV-2)
- 06.07.12
- Genocea Announces New Research Identifying Potential Vaccine Candidates for Chlamydia
- 04.11.12
- Novel T cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine
- 03.12.12
- Genocea to Present at the 8th International Symposium on Pneumococci and Pneumococcal Diseases
- 01.03.12
- Genocea to Present at Biotech Showcase™ 2012
Events
Sorry, there are currently no events scheduled.
© 2012 Genocea Company | Technology | Pipeline | Partnering | Publications & Presentations | News & Events | Site Credits